Azevedo LA, Matte U, Silveira TR, Bonfanti JW, Bruch JP, Álvares-da-Silva MR

Idioma: Ingles.
Referencias bibliográficas: 26
Paginas: 742-748
Archivo PDF: 255.46 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008; 134: 1655-69.

2. Lingala S, Ghany MG. Natural History of Hepatitis C. Gastroenterol Clin North Am 2015; 44: 717-34.

3. Iruzubieta P, Teran A, Crespo J, Fabrega E. Vitamin D deficiency in chronic liver disease. World J Hepatol 2014; 6: 901-15.

4. Stokes CS, Volmer DA, Grunhage F, Lammert F. Vitamin D in chronic liver disease. Liver International 2013; 33: 338-52.

5. Schottker B, Jorde R, Peasey A, Thorand B, Jansen EH, Groot L, Streppel M, et al. Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States. BMJ 2014; 348: g3656.

6. Stokes CS, Krawczyk M, Reichel C, Lammert F, Grunhage F. Vitamin D deficiency is associated with mortality in patients with advanced liver cirrhosis. Eur J Clin Invest 2014; 44: 176-83.

7. Christiansen M, Jorgensen CS, Laursen I, Hirschberg D, Hojrup P, Houen G. Protein chemical characterization of Gc globulin (vitamin D-binding protein) isoforms; Gc-1f, Gc-1s and Gc-2. Biochim Biophys Acta 2007; 1774: 481-92.

8. Arnaud J, Constans J. Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Hum Genet 1993; 92: 183-8.

9. Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D, Kiel DP, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010; 376: 180-8.

10. Ahn J, Yu K, Stolzenberg-Solomon R, Simon KC, McCullough ML, Gallicchio L, Jacobs EJ, et al. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 2010; 19: 2739-45.

11. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24: 289-93.

12. Pearce SH, Cheetham TD. Diagnosis and management of vitamin D deficiency. BMJ 2010; 340: b5664.

13. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Human Genetics 2001; 68: 978-89.

14. Stephens M, Scheet P. Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am J Human Genetics 2005; 76: 449-62.

15. Lange CM, Bibert S, Kutalik Z, Burgisser P, Cerny A, Dufour JF, Geier A, et al. A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfabased therapy of chronic hepatitis C. Plos One 2012; 7: e40159.

16. Konstantakis C, Tselekouni P, Kalafateli M, Triantos C. Vitamin D deficiency in patients with liver cirrhosis. Ann Gastroenterol 2016; 29: 297-306. Doi: 10.20524/aog.2016.0037.

17. Batai K, Murphy AB, Shah E, Ruden M, Newsome J, Agate S, Dixon MA, et al. Common vitamin D pathway gene variants reveal contrasting effects on serum vitamin D levels in African Americans and European Americans. Hum Genet 2014; 133: 1395-405.

18. Santos BR, Mascarenhas LPG, Boguszewski MCS, Spritzer PM. Variations in the Vitamin D-Binding Protein (DBP) Gene Are Related to Lower 25-Hydroxyvitamin D Levels in Healthy Girls: A Cross-Sectional Study. Hormone Research in Paediatrics 2013; 79: 162-8.

19. Baur K, Mertens JC, Schmitt J, Iwata R, Stieger B, Eloranta JJ, Frei P, et al. Combined effect of 25-OH vitamin D plasma levels and genetic Vitamin D Receptor (NR 1I1) variants on fibrosis progression rate in HCV patients. Liver International 2012; 32: 635-43.

20. Petta S, Grimaudo S, Di Marco V, Scazzone C, Macaluso FS, Camma C, Cabibi D, et al. Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients. J Viral Hepat 2013; 20: 486-93.

21. Lange CM, Bojunga J, Ramos-Lopez E, von Wagner M, Hassler A, Vermehren J, Herrmann E, et al. Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferonalfa based therapy. J Hepatol 2011; 54: 887-93.

22. Petta S, Grimaudo S, Di Marco V, Scazzone C, Macaluso FS, Camma C, Cabibi D, et al. Association of Vitamin D Serum Levels and Its Common Genetic Determinants, with Severity of Liver Fibrosis in Genotype 1 Chronic Hepatitis C Patients. J Hepatol 2013; 58: S194.

23. Grunhage F, Hochrath K, Krawczyk M, Hoblinger A, Obermayer- Pietsch B, Geisel J, Trauner M, et al. Common genetic variation in vitamin D metabolism is associated with liver stiffness. Hepatology 2012; 56: 1883-91.

24. Ding N, Yu RT, Subramaniam N, Sherman MH, Wilson C, Rao R, Leblanc M, et al. A Vitamin D Receptor/SMAD Genomic Circuit Gates Hepatic Fibrotic Response. Cell 2013; 153: 601-13.

25. Garcia-Alvarez M, Pineda-Tenor D, Jimenez-Sousa MA, Fernandez-Rodriguez A, Guzman-Fulgencio M, Resino S. Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: a meta-analysis. Hepatology 2014; 60: 1541-50.

26. Atsukawa M, Tsubota A, Shimada N, Yoshizawa K, Abe H, Asano T, Ohkubo Y, et al. Effect of native vitamin D3 supplementation on refractory chronic hepatitis C patients in simeprevir with pegylated interferon/ribavirin. Hepatol Res 2016; 46: 450-58.